COMMUNIQUÉS West-GlobeNewswire

VBL Therapeutics to Present Data on its MOSPD2 Oncology Program at MIXiii-BIOMED 2018 on May 15

07/05/2018 - 15:00

TEL AVIV, Israel, May 07, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]

Protech Home Medical Announces Approval of Corporate Name Change

07/05/2018 - 15:00

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, May 07, 2018 (GLOBE NEWSWIRE) -- Protech Home [...]

More than 60 Hospitals Embrace Artifact Health’s Mobile Technology to Accelerate Physician Query Workflow

07/05/2018 - 15:00

Artifact’s CEO invited to speak at HLTH, the “Future of Healthcare” event, on best practices for ensuring accurate quality data and proper reimbursement BOULDER, Colo., May 07, 2018 (GLOBE NEWSWIRE) -- Artifact Health [...]

Nymox Announces Relocation of Company Headquarters to Switzerland

07/05/2018 - 15:00

HASBROUCK HEIGHTS, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX ) is pleased to announce that it has initiated the process of relocating the Company Headquarters from Nassau, [...]

Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä

07/05/2018 - 14:51

ORION CORPORATION MANAGERS' TRANSACTIONS 7 MAY 2018 at 15.50 EETS Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä Orion Corporation has received the following disclosure under Market Abuse [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

07/05/2018 - 14:31

FIT Biotech Oy Company release May 7, 2018 at 3:30 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 between [...]

Marrone Bio Innovations Appoints Kevin Hammill as New Chief Commercial Officer

07/05/2018 - 14:31

Executive With Proven Track Record Brings MBI Over 25 Years of Agrochemical and Biologicals Experience DAVIS, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading [...]

Scythian Biosciences Announces Licensing Agreement With Isodiol International Inc.

07/05/2018 - 14:30

— Scythian Makes $2 Million Investment Alongside Serruya Private Equity, and the Delavaco Group — — Isodiol Recently Awarded the Highly Coveted UK Government Approval for Natural CBD Isolate as an Active Pharmceutical [...]

Alder BioPharmaceuticals® to Present at the 2018 Bank of America Merrill Lynch Health Care Conference

07/05/2018 - 14:30

BOTHELL, Wash., May 07, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]

International Stem Cell Corporation Granted Key Patent in US

07/05/2018 - 14:30

CARLSBAD, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based biotechnology company developing novel [...]

Menlo Therapeutics Announces Senior Clinical Leadership Updates

07/05/2018 - 14:30

REDWOOD CITY, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO ), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus associated [...]

Trading by management and close relations of management

07/05/2018 - 14:12

Read the full announcement in the attached file Attachment 2018_27_Trading_by_management_EN

Matinas BioPharma to Host Quarterly Update Conference Call

07/05/2018 - 14:05

Conference call with live audio webcast on Thursday, May 10th at 8:30 am EDT BEDMINSTER, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), a clinical-stage biopharmaceutical [...]

Samumed Presented Multiple Abstracts Supporting Potential Disease Modification at the Osteoarthritis Research Society International (OARSI) 2018 World Congress

07/05/2018 - 14:00

SAN DIEGO, May 07, 2018 (GLOBE NEWSWIRE) -- Samumed, LLC, a leader in Wnt research and development, presented its most recent clinical and preclinical data for two of the company’s investigational Wnt pathway inhibitors [...]

Foamix Announces Dosing of Last Patient in Third Phase 3 Acne Study for Minocycline Foam FMX101

07/05/2018 - 14:00

Top-line Results Expected in the Third Quarter of 2018 REHOVOT, Israel, and BRIDGEWATER, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX ), a clinical stage specialty pharmaceutical [...]

Daré Bioscience, Inc. Enters into Agreement to Acquire Product to Address Vulvar and Vaginal Atrophy in Hormone Receptor-Positive Breast Cancer Patients

07/05/2018 - 14:00

Agreement intends to broaden Company’s product portfolio within women’s reproductive health with novel clinical candidate, positioning Company with first in class candidates in contraception, sexual health and vaginal [...]

Biotech Industry Veteran Dietmar Berger, M.D., Ph.D., Joins Atara Biotherapeutics as Global Head of Research and Development

07/05/2018 - 14:00

Expanded R&D leadership team focused on rigorous late-stage clinical development and leveraging full potential of Atara’s technology platform SOUTH SAN FRANCISCO, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- Atara [...]

Optinose to Report First Quarter 2018 Financial Results and Corporate Updates on May 14, 2018

07/05/2018 - 14:00

Conference Call and Webcast Scheduled for Monday, May 14 at 8:00 a.m. Eastern Time YARDLEY, Pa., May 07, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ear, [...]

HTG Molecular Diagnostics and Firalis Announce an Agreement Enabling Firalis’ Commercialization of Theranostic and Research Products and Services Based on HTG EdgeSeq Technology

07/05/2018 - 14:00

TUCSON, Ariz. and HUNINGUE, France, May 07, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM ) (“HTG”), a provider of instruments, reagents and services for molecular profiling applications, and [...]